Gain Therapeutics
GANX
GANX
38 hedge funds and large institutions have $7.7M invested in Gain Therapeutics in 2025 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
35% less capital invested
Capital invested by funds: $11.9M → $7.7M (-$4.15M)
Holders
38
Holding in Top 10
–
Calls
$169K
Puts
–
Top Buyers
| 1 | +$375K | |
| 2 | +$246K | |
| 3 | +$191K | |
| 4 |
Morgan Stanley
New York
|
+$140K |
| 5 |
Jane Street
New York
|
+$128K |
Top Sellers
| 1 | -$5.36M | |
| 2 | -$179K | |
| 3 | -$82.8K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$23K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$20.8K |
